Lucid Diagnostics Inc. (LUCD) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Lucid Diagnostics Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.706 -- 00:00:05.973 Good morning and welcome to the Lucid Diagnostics First Quarter 2025 00:00:05.973 -- 00:00:10.499 Business Update Conference Call. Please note this event is being recorded. 00:00:10.499 -- 00:00:13.443 I would now like to turn the conference call over to Mr. 00:00:13.443 -- 00:00:18.029 Matt Riley, Lucid Diagnostics Senior Director of Investor Relations. 00:00:18.029 -- 00:00:20.470 Please go ahead. 00:00:22.535 -- 00:00:24.652 Thank you, Operator. Good morning, everyone. 00:00:24.652 -- 00:00:27.776 Thank you for participating in today's business update call. 00:00:27.776 -- 00:00:32.101 Joining me today on the call are Dr. Leshawn Ackog, Chairman and Chief Executive Officer 00:00:32.101 -- 00:00:37.147 of Lucid Diagnostics, along with Dennis McGrath, Chief Financial Officer. 00:00:37.147 -- 00:00:40.532 The press release announcing our business update and financial results is available on 00:00:40.532 -- 00:00:44.937 Lucid's website. Please take a moment to read the disclaimers about forward-looking statements 00:00:44.937 -- 00:00:49.082 in the press release. The business update, press release, and the conference call all 00:00:49.082 -- 00:00:53.137 include forward-looking statements and these forward-looking statements are subject to 00:00:53.137 -- 00:00:58.343 known and unknown risks and uncertainties that may cause actual results to differ materially 00:00:58.343 -- 00:01:00.405 from statements made. 00:01:00.405 -- 00:01:04.470 Factors that could cause actual results to differ are described in the disclaimer and 00:01:04.470 -- 00:01:08.995 in our filings with the SEC. For a list and a description of these and other important 00:01:08.995 -- 00:01:14.742 risks and uncertainties that may affect our future operations, see Pa...